Dr. Ware joined Chimerix in 2007 promoted to Vice President, Chemistry in 2015 and in 2017 was named Chief Manufacturing and Technology Officer. Prior to joining Chimerix, he worked at PharmaCore, Inc. and Scynexis, Inc. (contractor) in the areas of chemical process development and cGMP synthesis for various classes of compounds, including anti-cancer agents. Dr. Ware also contributed to oncology (PI3-kinase inhibitors) and malaria programs during his tenure at Serenex, Inc. where he led a team of medicinal chemists. Dr. Ware worked in the area of drug addiction therapy as a postdoctoral researcher at the Research Triangle Institute International under the direction of Dr. F. Ivy Carroll. He received his PhD from Wake Forest University, MBA from the Kenan-Flagler Business School at the University of North Carolina at Chapel Hill, and BA from the University of North Carolina at Greensboro.
This post was written by tbe_admin